Bharat Immunologicals Statements
52
Data from Bharat Immunologicals`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
INR - Indian rupee
Last reporting period:
31 Mar, 2023
Next reporting period:
27 Sep, 2023
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
25 Oct, 2024
Bharat Immunologicals Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
76.503
-79.3 %
100
139.35
145.9
-62.848
-84.2 %
-45.9
—
0
—
0
49.251
23.4 %
38.4
-112.1
-51.4 %
-84.3
-37.187
-26.8
23.4
29.2
-125.89
-22.7 %
-81.8
-36.117
-25.7
-89.769
-11.1 %
-56.1
-2.074
43.273
369.59
67.7 %
100
403.71
107
-34.123
-31.2 %
-7
—
0
—
0
39.911
297.8 %
2.6
-74.034
-105.5 %
-9.6
-33.226
-6.6
4.631
1.2
-102.63
-115.6 %
-15
-21.831
-3.3
-80.797
-716.4 %
-11.6
-1.87
43.249
220.41
26.4 %
100
246.4
111.8
-25.999
-149.1 %
-11.8
—
0
—
0
10.033
-76.7 %
4.6
-36.032
-469.6 %
-16.3
-16.693
-7.6
5.12
2.3
-47.605
-982.4 %
-21.6
-37.708
-17.1
-9.897
-200.5 %
-4.5
-0.213
46.497
174.31
-55.2 %
100
121.4
69.7
52.901
138.4 %
30.3
—
0
—
0
43.152
-9.9 %
24.8
9.749
137.9 %
5.6
-15.385
-8.8
1.238
0.7
-4.398
90.2 %
-2.5
-1.104
-0.6
-3.294
95.6 %
-1.9
-0.08
41.175
389.17
149.1 %
100
366.98
101.3
22.19
118 %
-1.3
—
0
—
0
47.888
96.1 %
13.1
-25.698
82.6 %
-14.4
-23.839
-5
4.666
0.9
-44.871
70.3 %
-18.5
29.474
19.4
-74.345
35.7 %
-37.9
-1.72
42.973
156.24
-38 %
100
279.7
179
-123.46
-3121.9 %
-79.02
—
0
—
0
24.423
25.2 %
15.6
-147.89
-533.8 %
-94.7
-12.243
-7.8
9.231
5.9
-150.9
-521.2 %
-96.6
-35.224
-22.5
-115.67
-510.5 %
-74.04
-2.657
43.534
251.99
-43.4 %
100
255.82
101.5
-3.832
-115.9 %
-1.5
—
0
—
0
19.502
-69.5 %
7.7
-23.334
41.5 %
-9.3
-12.961
-5.1
12.003
4.8
-24.292
63.7 %
-9.6
-5.345
-2.1
-18.947
59.3 %
-7.5
-0.44
43.061
445.11
-14 %
100
421.08
105.4
24.03
-64.6 %
-5.4
—
0
—
0
63.906
34.9 %
12.6
-39.876
-295 %
-18
-22.57
-4.6
-4.442
0.5
-66.888
-383.7 %
-22.03
-20.381
-6.8
-46.507
-428.8 %
-15.2
-1.077
43.18
517.35
242.6 %
100
449.52
77.1
67.833
193.2 %
22.9
—
0
—
0
47.387
-12.4 %
5.2
20.446
116.1 %
17.7
-25.92
-4.2
-8.355
-5.6
-13.829
89.2 %
7.8
-27.974
-8.4
14.145
112.2 %
16.2
0.354
42.813
151.01
217.3 %
100
223.83
157.9
-72.82
-289.3 %
-57.9
—
0
—
0
54.078
36.9 %
25.5
-126.9
-118 %
-83.3
-21.497
-15.4
20.192
2.2
-128.2
-133 %
-96.6
-11.945
-26.7
-116.26
-198.6 %
-69.9
-2.637
44.085
47.589
—
100
66.293
139.3
-18.704
—
-39.3
—
0
—
0
39.498
—
83
-58.202
—
-122.3
-1.263
-2.7
4.431
9.3
-55.034
—
-115.6
-16.104
-33.8
-38.93
—
-81.8
-0.903
43.116